Manager × security

ARK Investment Management LLC CRSP holdings history

Who else holds this security?

CRISPR THERAPEUTICS AG · CUSIP H17182108 · CIK 1697748

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, ARK Investment Management LLC reported 9.46M CRSP (shares), valued at $516.00M, or 3.35% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources
Portfolio weight and quantity history
Reported portfolio weight
3.35%
Shares
9.46M
9,460,939
Reported value
$516.00M
USD

Shares decreased 16.38%; reported value decreased 4.12%, and weight changed -0.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20263.35%9,460,939SEC filingFiled Aug 14, 2026
Q1 20264.19%11,313,623SEC filingFiled May 12, 2026
Q4 20253.66%10,522,057SEC filingFiled Feb 11, 2026
Q3 20253.78%9,786,973SEC filingFiled Nov 12, 2025
Q2 20253.63%10,182,590SEC filingFiled Jul 30, 2025
Q1 20253.46%10,165,400SEC filingFiled May 7, 2025
Q4 20242.94%8,973,064SEC filingFiled Feb 4, 2025
Q3 20243.22%7,498,625SEC filingFiled Oct 31, 2024
Q2 20243.73%7,778,536SEC filingFiled Jul 26, 2024
Q1 20243.85%8,157,028SEC filingFiled Apr 18, 2024
Q4 20233.16%8,536,104SEC filingFiled Jan 17, 2024
Q3 20232.49%7,163,118SEC filingFiled Oct 18, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20232.49%7,163,118$325.13MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing
Filed Oct 18, 2023
Q4 20233.16%8,536,104$534.36MShares increased 19.17%; reported value increased 64.35%, and weight changed +0.67 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Jan 17, 2024
Q1 20243.85%8,157,028$555.98MShares decreased 4.44%; reported value increased 4.05%, and weight changed +0.69 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Apr 18, 2024
Q2 20243.73%7,778,536$420.12MShares decreased 4.64%; reported value decreased 24.44%, and weight changed -0.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Jul 26, 2024
Q3 20243.22%7,498,625$352.29MShares decreased 3.60%; reported value decreased 16.15%, and weight changed -0.51 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Oct 31, 2024
Q4 20242.94%8,973,064$353.18MShares increased 19.66%; reported value increased 0.25%, and weight changed -0.28 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 4, 2025
Q1 20253.46%10,165,400$345.93MShares increased 13.29%; reported value decreased 2.05%, and weight changed +0.52 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 7, 2025
Q2 20253.63%10,182,590$495.28MShares increased 0.17%; reported value increased 43.17%, and weight changed +0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Jul 30, 2025
Q3 20253.78%9,786,973$634.29MShares decreased 3.89%; reported value increased 28.07%, and weight changed +0.15 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Nov 12, 2025
Q4 20253.66%10,522,057$551.78MShares increased 7.51%; reported value decreased 13.01%, and weight changed -0.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 11, 2026
Q1 20264.19%11,313,623$538.19MShares increased 7.52%; reported value decreased 2.46%, and weight changed +0.53 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 12, 2026
Q2 20263.35%9,460,939$516.00MShares decreased 16.38%; reported value decreased 4.12%, and weight changed -0.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 14, 2026
ARK Investment Management LLC · CRISPR THERAPEUTICS AG

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1697748","quarter":"2026Q2","cusip":"H17182108"}

get_institutional_manager_history
{"cik":"1697748","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.